The Relationship between D-dimer test and COVID-19

المؤلفون

  • Randa Mohamed Elsalhi Department of Medical laboratories sciences, Misurata University, Misurata, Libya. ,
  • Fatma Milad Alzin Department of Medical laboratories sciences, Misurata University, Misurata, Libya.
  • Mustafa Mohammed Drah Department of Zoology, Misurata University, Misurata, Libya.
  • Amna Mustafa Bayo Department of Zoology, Misurata University, Misurata, Libya

الكلمات المفتاحية:

Prevalence COVID-19، dimer test، Integra system، Thrombosis

الملخص

Background: COVID-19 is common disease in the world, and it has caused many complications to humans, D-dimers have been shown to be of prognostic value in various diseases, including cardiovascular disease and cancer, and D-dimer is currently the best available marker for COVID-19 associated hemostatic abnormalities. The objective of this study was found the relationship between D-dimer and COVID-19 in the patients.  

Methods: In this study 3913 samples were collected from patient with COVID-19, from January 2020 to April 2021,  A D-dimer test was conducted at the Misurata Central Laboratory, the Most of the cases that have a high D-dimer protein result have serious complications such as thrombosis and pulmonary embolisms.

The normal range of D-dimer was taken as <0.5 mg/dl as per our laboratory standards. A convenience sampling method was used.

Results: Out of the total 3913 cases of COVID-19 included in this study, 1551 (39.64%) patients had elevated D-dimer by using Integra 400 plus system (P value <0.05) by SPSS.

المراجع

(1) Prompetchara, E., Ketloy, C., & Palaga, T. (2020). Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pacific journal of allergy and immunology, 38(1), 1-9.‏

(2) Guo, Y. R., Cao, Q. D., Hong, Z. S., Tan, Y. Y., Chen, S. D., Jin, H. J., ... and Yan, Y. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Military Medical Research, 7(1), 1-10

(3) Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., ... and Feng, Z. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England journal of medicine.‏

(4) Adam, S. S., Key, N. S., and Greenberg, C. S. (2009). D-dimer antigen: current concepts and future prospects. Blood, The Journal of the American Society of Hematology, 113(13), 2878-2887.‏

(5) Khatri, P., Agrawal, K. K., Sharma, D., Chhetri, P., Neupane, A., Piriyani, R. M., ... & Bharali, S. (2021). Prevalence of Elevated D-dimer Levels in Confirmed COVID-19 Cases in Intensive Care Unit of a Tertiary Care Centre of Western Nepal. Journal of the Nepal Medical Association, 59(235).‏

(6) Tasić, N., Paixão, T. R., and Gonçalves, L. M. (2020). Biosensing of D-dimer, making the transition from the central hospital laboratory to bedside determination. Talanta, 207, 120270.‏

(7) Adam, S. S., Key, N. S., and Greenberg, C. S. (2009). D-dimer antigen: current concepts and future prospects. Blood, The Journal of the American Society of Hematology, 113(13), 2878-2887.‏

(8) Song, X., Ji, J., Reva, B., Joshi, H., Calinawan, A. P., Mazumdar, M., ... & Veluswamy, R. R. (2021). Post-anticoagulant D-dimer is a highly prognostic biomarker of COVID-19 mortality. ERJ Open Research.‏

(9) Velavan, T. P., & Meyer, C. G. (2020). Mild versus severe COVID-19: laboratory markers. International Journal of Infectious Diseases, 95, 304-307.‏

التنزيلات

منشور

2024-01-01

كيفية الاقتباس

Elsalhi , R. M., Alzin, F. M., Drah, M. M., & Bayo, A. M. (2024). The Relationship between D-dimer test and COVID-19. مجلة البحوث الأكاديمية, 28, 56–54. استرجع في من https://lam-journal.ly/index.php/jar/article/view/479

إصدار

القسم

المقالات

الأعمال الأكثر قراءة لنفس المؤلف/المؤلفين